Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma
Anticancer Research · 2024
DOI: 10.21873/anticanres.16869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ryo Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan; rsato02@hama-med.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Antineoplastic Agents, Kidney Neoplasms, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan; rsato02@hama-med.ac.jp.
- Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Urology, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
- Department of Developed Studies for Advanced Robotic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Urology, Hamamatsu Medical Center, Hamamatsu, Japan.
- Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Zitieren
APA
Sato, R., Matsushita, Y., Takemura, A., Sugiyama, M., Watanabe, K., Watanabe, H., Tamura, K., Motoyama, D., Nagata, M., Otsuka, A., Furuse, H., & Miyake, H. (2024). Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.16869
Vancouver
Sato R, Matsushita Y, Takemura A, Sugiyama M, Watanabe K, Watanabe H, et al. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.16869
BibTeX
@article{Sato2024,
author = {Sato, Ryo and Matsushita, Yuto and Takemura, Ayana and Sugiyama, Momoko and Watanabe, Kyohei and Watanabe, Hiromitsu and Tamura, Keita and Motoyama, Daisuke and Nagata, Masao and Otsuka, Atsushi and Furuse, Hiroshi and Miyake, Hideaki},
title = {Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16869}
}
EUVIMED